AMSTERDAM (Reuters) – Drugmaker Johnson & Johnson is unsure it can meet a target of delivering 55 million doses of its COVID-19 vaccine to the European Union by the end of the second quarter, Dutch national broadcaster NOS said, citing J&J’s Dutch subsidiary.
NOS attributed the company’s uncertainty to difficulties around production of the vaccine at a U.S. facility. A spokeswoman for the Janssen subsidiary of J&J in the Netherlands could not immediately be reached to confirm the NOS report.
(Reporting by Toby Sterling; Editing by Mark Heinrich)
